AstraZeneca Pressure Mounts as Investors Await Oxford Vaccine Data
A logo sits at AstraZeneca Plc’s facilities in Sweden. (Photographer: Mikael Sjoberg/Bloomberg)

AstraZeneca Pressure Mounts as Investors Await Oxford Vaccine Data

(Bloomberg) -- Pressure is growing on AstraZeneca Plc to deliver positive results from early tests evaluating the coronavirus vaccine it’s developing with University of Oxford researchers as invest...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.